WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today presented new preclinical data on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback